RET and differentiated thyroid carcinoma: Classic papillary thyroid carcinoma (PTC-classic) are infiltrative, often metastasize to lymph nodes, and frequently harbor BRAFV600E mutations (~45%), RET-PTC rearrangements (~20%), and/or a BRAFV600E-like gene expression signature [1–3].